Keyboard design for phase I drug-combination trials
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 92, 105972
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 31 references indexed in Scilit:
- A Bayesian Dose-finding Design for Drug Combination Trials with Delayed ToxicitiesBayesian Analysis, 2013
- Continual Reassessment Method for Partial OrderingBiometrics, 2011
- A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic AgentsBiometrics, 2009
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two AgentsBiometrics, 2009
- Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical TrialsJournal of the American Statistical Association, 2009
- Dose Escalation Methods in Phase I Cancer Clinical TrialsJNCI: Journal of the National Cancer Institute, 2009
- Bayesian Dose Finding in Oncology For Drug Combinations by Copula RegressionJournal of the Royal Statistical Society Series C: Applied Statistics, 2009
- Sequential continual reassessment method for two‐dimensional dose findingStatistics in Medicine, 2008
- Cumulative cohort design for dose-findingJournal of Statistical Planning and Inference, 2007
- Improved up‐and‐down designs for phase I trialsStatistics in Medicine, 2002